Back | Next |
home / stock / drma / drma message board
Subject | By | Source | When |
---|---|---|---|
Retest $3.68 everyone READY?? We still have | reena969 | investorshub | 04/18/2023 12:41:04 PM |
Look at these robots trade hands. | Awl416 | investorshub | 04/18/2023 12:40:06 PM |
I thought MOCM was going to shut our | reena969 | investorshub | 04/18/2023 12:38:54 PM |
Well, it's blowing up now. $3.50 | subslover | investorshub | 04/18/2023 12:38:37 PM |
You have to understand the psychology of the | reena969 | investorshub | 04/18/2023 12:36:52 PM |
To think they flushed out probably 2m shares | Awl416 | investorshub | 04/18/2023 12:34:18 PM |
Only 7 million volume of PM trading, | reena969 | investorshub | 04/18/2023 12:26:42 PM |
$DRMA 3.20'S CONGRAT$ | TheFinalCD | investorshub | 04/18/2023 12:20:45 PM |
I watched level 2 all day yesterday Still scratching | Awl416 | investorshub | 04/18/2023 12:08:46 PM |
2 choices goes back to $1.50s support or | tw0122 | investorshub | 04/18/2023 11:29:34 AM |
https://finviz.com/quote.ashx?t=$DRMA&ty=c&ta=1&p=d 70% PM micro float | reena969 | investorshub | 04/18/2023 8:06:40 AM |
I see what you mean. Closed AH $2.42 | subslover | investorshub | 04/18/2023 12:11:28 AM |
What a funky movement to finish the day | Awl416 | investorshub | 04/17/2023 8:33:33 PM |
Found an interesting article | reena969 | investorshub | 04/17/2023 7:57:17 PM |
High $2.48 now $1.41 | subslover | investorshub | 04/17/2023 12:07:52 PM |
MomentumIts trading | Awl416 | investorshub | 04/16/2023 3:07:04 AM |
$DRMA.............................https://stockcharts.com/h-sc/ui?s=$DRMA&p=W&b=5& | glenn1919 | investorshub | 04/15/2023 7:23:42 PM |
$DRMA best news of the day | Awl416 | investorshub | 04/15/2023 7:12:34 AM |
$DRMA MomentumIts gaining up | Awl416 | investorshub | 04/15/2023 1:25:11 AM |
$DRMA Price now | glenn1919 | investorshub | 04/14/2023 10:37:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Dermata Therapeutics Inc. Company Name:
DRMA Stock Symbol:
NASDAQ Market:
SAN DIEGO, CA / ACCESSWIRE / May 17, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced the entry into definitive agreement...
- DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial enrollment remains on track - - Dermata continues discussions with potential botulinum toxin partners for DMT410 - - Received issuance of Japanese patent for DMT410 for the treatment of hyperhidrosis - SAN...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...